BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-445@pharmaconomics
DTSTAMP:20260707T013705Z
DTSTART;VALUE=DATE:20260109
DTEND;VALUE=DATE:20260110
SUMMARY:ATRA CRL — EBVALLO™
DESCRIPTION:An FDA complete response letter on EBVALLO™ for its lead indication is in focus around Jan 9\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1604464/000119312526086793/d121575d8k.htm\n\nTrack it: https://pharmaconomics.com/e/445
URL:https://pharmaconomics.com/e/445
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ATRA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR